Author Contributions Conceived and designed the experiments: KSEC. Performed the experiments: VYLL BG KKHL IGM SLW TYKA NWFD JYBL ACYM. References 1. Alman BA (2008) Skeletal dysplasias and the growth plate. Clin Genet 73: 24–30. 2. Karsenty G (2008) Transcriptional control of skeletogenesis. Annu Rev Genomics Hum Genet 9: 183–196. 3. Kronenberg HM (2006) PTHrP and skeletal development. Ann N Y Acad Sci 1068: 1–13. 4. Bi W, Deng JM, Zhang Z, Behringer RR, De Crombrugghe B (1999) Sox9 is required for cartilage formation. Nat Genet 22: 85–89. 5. Bi W, Huang W, Whitworth DJ, Deng JM, Zhang Z, et al. (2001) Haploinsufficiency of Sox9 results in defective cartilage primordia and premature skeletal mineralization. Proc Natl Acad Sci U S A 98: 6698–6703. 6. Akiyama H, Chaboissier MC, Martin JF, Schedl A, De Crombrugghe B (2002) The transcription factor Sox9 has essential roles in successive steps of the chondrocyte differentiation pathway and is required for expression of Sox5 and Sox6. Genes Dev 16: 2813–2828. 7. Ikegami D, Akiyama H, Suzuki A, Nakamura T, Nakano T, et al. (2011) Sox9 sustains chondrocyte survival and hypertrophy in part through Pik3ca-Akt pathways. Development 138: 1507–1519. 8. Zhao Q, Eberspaecher H, Lefebvre V, De-Crombrugghe B (1997) Parallel expression of Sox9 and Col2a1 in cells undergoing chondrogenesis. Dev Dyn 209: 377–386. 9. Ng LJ, Wheatley S, Muscat GE, Conway CJ, Bowles J, et al. (1997) SOX9 binds DNA, activates transcription, and coexpresses with type II collagen during chondrogenesis in the mouse. Dev Biol 183: 108–121. 10. Bell DM, Leung KK, Wheatley SC, Ng LJ, Zhou S, et al. (1997) SOX9 directly regulates the type-II collagen gene. Nat Genet 16: 174–178. 11. Lefebvre V, Huang W, Harley VR, Goodfellow PN, De-Crombrugghe B (1997) SOX9 is a potent activator of the chondrocyte-specific enhancer of the pro alpha1(II) collagen gene. Mol Cell Biol 17: 2336–2346. 12. Liu Y, Li H, Tanaka K, Tsumaki N, Yamada Y (2000) Identification of an enhancer sequence within the first intron required for cartilage-specific transcription of the alpha2(XI) collagen gene. J Biol Chem 275: 12712–12718. 13. Sekiya I, Tsuji K, Koopman P, Watanabe H, Yamada Y, et al. (2000) SOX9 enhances aggrecan gene promoter/enhancer activity and is up-regulated by retinoic acid in a cartilage-derived cell line, TC6. J Biol Chem 275: 10738–10744. 14. Xie WF, Zhang X, Sakano S, Lefebvre V, Sandell LJ (1999) Trans-activation of the mouse cartilage-derived retinoic acid-sensitive protein gene by Sox9. J Bone Miner Res 14: 757–763. 15. Han Y, Lefebvre V (2008) L-Sox5/Sox6 Drive Expression of the Aggrecan Gene in Cartilage by Securing Binding of Sox9 to a Far-upstream Enhancer. Mol Cell Biol 28: 4999–5013. 16. Rosati R, Horan GS, Pinero GJ, Garofalo S, Keene DR, et al. (1994) Normal long bone growth and development in type X collagen-null mice. Nat Genet 8: 129–135. 17. Kwan KM, Pang MK, Zhou S, Cowan SK, Kong RY, et al. (1997) Abnormal compartmentalization of cartilage matrix components in mice lacking collagen X: implications for function. J Cell Biol 136: 459–471. 18. Ho MS, Tsang KY, Lo RL, Susic M, Makitie O, et al. (2007) COL10A1 nonsense and frame-shift mutations have a gain-of-function effect on the growth plate in human and mouse metaphyseal chondrodysplasia type Schmid. Hum Mol Genet 16: 1201–1215. 19. Chambers D, Young DA, Howard C, Thomas JT, Boam DS, et al. (2002) An enhancer complex confers both high-level and cell-specific expression of the human type X collagen gene. FEBS Lett 531: 505–508. 20. Lefebvre V, Li P, De Crombrugghe B (1998) A new long form of Sox5 (L-Sox5), Sox6 and Sox9 are coexpressed in chondrogenesis and cooperatively activate the type II collagen gene. EMBO J 17: 5718–5733. 21. Tsang KY, Chan D, Cheslett D, Chan WC, So CL, et al. (2007) Surviving endoplasmic reticulum stress is coupled to altered chondrocyte differentiation and function. PLoS Biol 5: e44. 22. Scott CE, Wynn SL, Sesay A, Cruz C, Cheung M, et al. (2010) SOX9 induces and maintains neural stem cells. Nature neuroscience 13: 1181–1189. 23. Wilson M, Koopman P (2002) Matching SOX: partner proteins and co-factors of the SOX family of transcriptional regulators. Curr Opin Genet Dev 12: 441–446. 24. Kamachi Y, Cheah KSE, Kondoh H (1999) Mechanism of regulatory target selection by the SOX high-mobility-group domain proteins as revealed by comparison of SOX1/2/3 and SOX9 [In Process Citation]. Mol Cell Biol 19: 107–120. 25. Zhou R, Bonneaud N, Yuan CX, de Santa Barbara P, Boizet B, et al. (2002) SOX9 interacts with a component of the human thyroid hormone receptor- associated protein complex. Nucleic Acids Res 30: 3245–3252. 26. Nishioka K, Itoh S, Suemoto H, Kanno S, Gai Z, et al. (2008) Trps1 deficiency enlarges the proliferative zone of growth plate cartilage by upregulation of Pthrp. Bone 43: 64–71. SOX9 Is an Activator and Repressor in Chondrocytes Analyzed the data: VYLL BG KKHL IGM SLW TYKA ACYM DC KSEC. Wrote the paper: VYLL KSEC. 27. Wuelling M, Kaiser FJ, Buelens LA, Braunholz D, Shivdasani RA, et al. (2009) Trps1, a regulator of chondrocyte proliferation and differentiation, interacts with the activator form of Gli3. Dev Biol 328: 40–53. 28. Vega RB, Matsuda K, Oh J, Barbosa AC, Yang X, et al. (2004) Histone deacetylase 4 controls chondrocyte hypertrophy during skeletogenesis. Cell 119: 555–566. 29. Mau E, Whetstone H, Yu C, Hopyan S, Wunder JS, et al. (2007) PTHrP regulates growth plate chondrocyte differentiation and proliferation in a Gli3 dependent manner utilizing hedgehog ligand dependent and independent mechanisms. Dev Biol 305: 28–39. 30. Koyama E, Young B, Nagayama M, Shibukawa Y, Enomoto-Iwamoto M, et al. (2007) Conditional Kif3a ablation causes abnormal hedgehog signaling topography, growth plate dysfunction, and excessive bone and cartilage formation during mouse skeletogenesis. Development 134: 2159–2169. 31. Ruiz i Altaba A, Mas C, Stecca B (2007) The Gli code: an information nexus regulating cell fate, stemness and cancer. Trends in cell biology 17: 438–447. 32. Eames BF, Sharpe PT, Helms JA (2004) Hierarchy revealed in the specification of three skeletal fates by Sox9 and Runx2. Dev Biol 274: 188–200. 33. Zhou G, Zheng Q, Engin F, Munivez E, Chen Y, et al. (2006) Dominance of SOX9 function over RUNX2 during skeletogenesis. Proc Natl Acad Sci U S A 103: 19004–19009. 34. Saito T, Ikeda T, Nakamura K, Chung UI, Kawaguchi H (2007) S100A1 and S100B, transcriptional targets of SOX trio, inhibit terminal differentiation of chondrocytes. EMBO Rep 8: 504–509. 35. Yamashita S, Andoh M, Ueno-Kudoh H, Sato T, Miyaki S, et al. (2009) Sox9 directly promotes Bapx1 gene expression to repress Runx2 in chondrocytes. Exp Cell Res 315: 2231–2240. 36. Riemer S, Gebhard S, Beier F, Poschl E, von der M (2002) Role of c-fos in the regulation of type X collagen gene expression by PTH and PTHrP: Localization of a PTH/PTHrP-responsive region in the human COL10A1 enhancer. J Cell Biochem 86: 688–699. 37. Zheng Q, Zhou G, Morello R, Chen Y, Garcia-Rojas X, et al. (2003) Type X collagen gene regulation by Runx2 contributes directly to its hypertrophic chondrocyte-specific expression in vivo. J Cell Biol 162: 833–842. 38. Arnold MA, Kim Y, Czubryt MP, Phan D, McAnally J, et al. (2007) MEF2C transcription factor controls chondrocyte hypertrophy and bone development. Dev Cell 12: 377–389. 39. Guo J, Chung UI, Yang D, Karsenty G, Bringhurst FR, et al. (2006) PTH/ PTHrP receptor delays chondrocyte hypertrophy via both Runx2-dependent and -independent pathways. Dev Biol 292: 116–128. 40. Inada M, Yasui T, Nomura S, Miyake S, Deguchi K, et al. (1999) Maturational disturbance of chondrocytes in Cbfa1-deficient mice. Dev Dyn 214: 279–290. 41. Lu VP, Iwamoto M, Fanning P, Pacifici M, Olsen BR (1993) Multiple negative elements in a gene that codes for an extracellular matrix protein, collagen X, restrict expression to hypertrophic chondrocytes. J Cell Biol 121: 1173–1179. 42. Magee C, Nurminskaya M, Faverman L, Galera P, Linsenmayer TF (2005) SP3/SP1 transcription activity regulates specific expression of collagen type X in hypertrophic chondrocytes. J Biol Chem 280: 25331–25338. 43. Gebhard S, Poschl E, Riemer S, Bauer E, Hattori T, et al. (2004) A highly conserved enhancer in mammalian type X collagen genes drives high levels of tissue-specific expression in hypertrophic cartilage in vitro and in vivo. Matrix Biol 23: 309–322. 44. Hattori T, Muller C, Gebhard S, Bauer E, Pausch F, et al. (2010) SOX9 is a major negative regulator of cartilage vascularization, bone marrow formation and endochondral ossification. Development 137: 901–911. 45. Kondoh H, Kamachi Y (2009) SOX-partner code for cell specification: Regulatory target selection and underlying molecular mechanisms. Int J Biochem Cell Biol 42: 391–399. 46. Akiyama H, Stadler HS, Martin JF, Ishii TM, Beachy PA, et al. (2007) Misexpression of Sox9 in mouse limb bud mesenchyme induces polydactyly and rescues hypodactyly mice. Matrix Biol 26: 224–233. 47. St-Jacques B, Hammerschmidt M, McMahon AP (1999) Indian hedgehog signaling regulates proliferation and differentiation of chondrocytes and is essential for bone formation. Genes Dev 13: 2072–2086. 48. Mo R, Freer AM, Zinyk DL, Crackower MA, Michaud J, et al. (1997) Specific and redundant functions of Gli2 and Gli3 zinc finger genes in skeletal patterning and development. Development 124: 113–123. 49. Park HL, Bai C, Platt KA, Matise MP, Beeghly A, et al. (2000) Mouse Gli1 mutants are viable but have defects in SHH signaling in combination with a Gli2 mutation. Development 127: 1593–1605. 50. Jiang J, Hui CC (2008) Hedgehog signaling in development and cancer. Dev Cell 15: 801–812. 51. Joeng KS, Long F (2009) The Gli2 transcriptional activator is a crucial effector for Ihh signaling in osteoblast development and cartilage vascularization. Development 136: 4177–4185. PLoS Genetics | www.plosgenetics.org 15 November 2011 | Volume 7 | Issue 11 | e1002356